WO2008111862A3 - Procédés et compositions pour la manipulation d'embryons mammifères - Google Patents

Procédés et compositions pour la manipulation d'embryons mammifères Download PDF

Info

Publication number
WO2008111862A3
WO2008111862A3 PCT/NZ2008/000055 NZ2008000055W WO2008111862A3 WO 2008111862 A3 WO2008111862 A3 WO 2008111862A3 NZ 2008000055 W NZ2008000055 W NZ 2008000055W WO 2008111862 A3 WO2008111862 A3 WO 2008111862A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
mammalian embryos
manipulating
manipulating mammalian
Prior art date
Application number
PCT/NZ2008/000055
Other languages
English (en)
Other versions
WO2008111862A2 (fr
Inventor
Laurence William Chamley
Valerie Jean Grant
Original Assignee
Auckland Uniservices Ltd
Laurence William Chamley
Valerie Jean Grant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auckland Uniservices Ltd, Laurence William Chamley, Valerie Jean Grant filed Critical Auckland Uniservices Ltd
Publication of WO2008111862A2 publication Critical patent/WO2008111862A2/fr
Publication of WO2008111862A3 publication Critical patent/WO2008111862A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8771—Bovine embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention concerne des procédés in vitro qui permettent d'agir sur le sexe des embryons mammifères produits in vitro. De plus, l'invention concerne des compositions utilisées dans ces procédés.
PCT/NZ2008/000055 2007-03-14 2008-03-14 Procédés et compositions pour la manipulation d'embryons mammifères WO2008111862A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ553837 2007-03-14
NZ55383707 2007-03-14

Publications (2)

Publication Number Publication Date
WO2008111862A2 WO2008111862A2 (fr) 2008-09-18
WO2008111862A3 true WO2008111862A3 (fr) 2008-12-24

Family

ID=39760228

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NZ2008/000055 WO2008111862A2 (fr) 2007-03-14 2008-03-14 Procédés et compositions pour la manipulation d'embryons mammifères

Country Status (1)

Country Link
WO (1) WO2008111862A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070155710A1 (en) * 2004-10-26 2007-07-05 Norbert Gleicher Androgen Treatment in Females

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070155710A1 (en) * 2004-10-26 2007-07-05 Norbert Gleicher Androgen Treatment in Females

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GRANT V.J. ET AL.: "Follicular Fluid Steroid Levels and Subsequent Sex of Bovine Embryos", JOURNAL OF EXPERIMENTAL ZOOLOGY, vol. 303A, 2005, pages 1120 - 1125 *
GRANT V.J. ET AL.: "Sex of Bovine Embryos May be Related to Mother's Preovulatory Follicular Testosterone", BIOLOGY OF REPRODUCTION, vol. 78, 2008, pages 812 - 815 *
JAMES W.H.: "Further Evidence That Mammalian Sex Ratios at Birth are Partially Controlled by Parental Hormone Levels Around the Time of Conception", HUMAN REPRODUCTION, vol. 19, no. 6, 2004, pages 1250 - 1256 *

Also Published As

Publication number Publication date
WO2008111862A2 (fr) 2008-09-18

Similar Documents

Publication Publication Date Title
WO2010062863A3 (fr) Compositions contenant des satiogènes et leurs procédés d'utilisation
BRPI0506839A (pt) composições e métodos para induzir a cardiomiogênese
AU2016204344A1 (en) Improved methods and compositions for wound healing
WO2009111586A3 (fr) Évolution autonome in vitro
DK201200196A (en) Imaging and evaulating embryos, oocytes, and stem cells
WO2009099719A3 (fr) Compositions et procédés de traitement d'une tumeur d'origine hématopoïétique
EP2432462A4 (fr) Procédés et compositions d'endoxifène pour traiter des maladies de mammifères
AU308855S (en) Camera
WO2007089798A3 (fr) Méthodes pour préparer et caractériser des aggrégats de cellules souches mésenchymateuses et leurs utilisations
MX2010000348A (es) Cultivo de celulas madre pluripotentes individuales.
WO2008085221A3 (fr) Utilisation thérapeutique de cellules exprimant cd31
WO2007097993A3 (fr) Milieu conditionné par des cellules souches embryonnaires humaines ou autres cellules progénitrices et son utilisation
EP2029754A4 (fr) Expression du gène codant pour les magnétosomes dans des cellules eucaryotes
WO2012012737A3 (fr) Treg stables et matériels et procédés associés
EP2518150A3 (fr) Oligonucléotide de triphosphate 5 avec extrémité franche et utilisations associées
MY173526A (en) Novel anti-?5?1 antibodies and uses thereof
WO2007145672A3 (fr) Combinaisons de protéines humaines destinées à accroître la viabilité de cellules souches et de cellules progénitrices
WO2009130616A3 (fr) Compositions agonistes de tlr3 améliorées
WO2009015037A3 (fr) Indazoles substitués par du 5-pyridinone
IN2012DN03404A (fr)
WO2011064549A3 (fr) Composition et procédé de différentiation de cellules souches embryonnaires humaines
WO2010011622A9 (fr) Compositions ophtalmiques contenant du gallium et procédés pour les utiliser
WO2010041145A3 (fr) Procédés de transfection médiée par il-17
WO2008111862A3 (fr) Procédés et compositions pour la manipulation d'embryons mammifères
IL206440A0 (en) Use of il-17 for maturation of oocytes

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08741748

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08741748

Country of ref document: EP

Kind code of ref document: A2